Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + remifentanil vs propofol + remifentanil for painless bronchoscopy in children
ChiCTR2500105332Phase 4Not yet recruiting
- Sponsor
- Zhongshan Boai Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Zhongshan Boai Hospital. Primary endpoint: Incidence of hypoxemia (SpO2 < 90%). Planned start Jul 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500105332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105332.